GSK Korea (Robert Kempton, CEO of Korean corporation) announced on the 24th that it will release a 90-capsule large-capacity package of Duodart, a treatment for prostatic hyperplasia. With this release, one package can be taken for three months. The recommended dosage of Duodart is 1 capsule once daily. The Duodart 90-capsule package was sequentially supplied to wholesalers nationwide starting this month. Duodart is a 5α-reductase inhibitor (Dutasteride) + α-blocker (Tamsulosin hydrochloride) fixed-dose combination drug that was first released in Korea. The two ingredients are contained in one capsule to improve symptoms quickly and reduce the long-term risk of disease progression. It can be